SCS 18.01 Steelcase Inc $SCS Hit a 52 week high of 18.14

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SCS 18.01 Steelcase Inc $SCS Hit a 52 week high of 18.14 Closing the day 11/06/14 at 18.01 +0.15 +0.84% With a day low of 17.81 and a total volume of 453,962.

SCS Recent Posts: http://investorshangout.com/Steelcase-Inc-SCS-52595/

SCS Steelcase Inc Recent Headline News

Staples Study Shows Small Business Owners Working in Pain
Business Wire - Tue Oct 21, 7:01AM CDT
Many small business owners and their employees are sitting in pain, according to a new study released by Staples (NASDAQ: SPLS) and Steelcase.
SPLS: 12.91 (-0.05), SCS: 18.01 (+0.15)

Steelcase Earnings In Retrospect: Down 2.5% in the Last 20 Days (SCS)
Comtex SmarTrend(R) - Mon Oct 13, 6:58AM CDT
When Steelcase (NYSE:SCS) reported earnings two weeks ago on September 23rd, 2014, analysts, on average, expected the company to report earnings of $0.23 on sales of $784.7 million. Steelcase actually reported earnings of $0.27 per share on sales of $786.7 million, beating EPS estimates by $0.04 and beating revenue estimates by $2.0 million. Shares of Steelcase have slipped from $15.63 to $15.24, representing a loss of 2.5%, since the company reported earnings 20 days ago.
SCS: 18.01 (+0.15)

NYSE stocks posting largest percentage increases
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
MHR: 4.19 (-0.05), IMPR: 14.84 (-0.29), AAV: 4.56 (+0.29), DOM: 7.40 (+0.01), SWFT: 25.32 (+0.30), GDP: 7.47 (-0.13), AAV.TO: 5.22 (+0.35), SCS: 18.01 (+0.15), GDOT: 22.20 (+0.10), SKX: 57.71 (+2.44)

Steelcase Declares Quarterly Dividend
GlobeNewswire - Thu Sep 25, 1:31PM CDT
The Board of Directors of Steelcase Inc. (NYSE:SCS) today declared a quarterly cash dividend of $0.105 per share to be paid on or before October 16, 2014 to shareholders of record as of October 6, 2014.
SCS: 18.01 (+0.15)

Company News for September 25, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 9:10AM CDT
Companies in the News are: PAYX,AIR,SCS,CPRT
PAYX: 47.57 (-0.20), SCS: 18.01 (+0.15), CPRT: 34.01 (+0.45), AIR: 26.47 (+0.39)

Steelcase Inc. (SCS) Jumps: Stock Adds 7.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 8:11AM CDT
Steelcase Inc. (SCS) was a big mover last session, as the company saw its shares rise over 7% on the day.
HAIN: 107.84 (+2.18), ARMK: 28.66 (+0.26), SCS: 18.01 (+0.15), MLHR: 31.46 (+0.33)

Why Steelcase (SCS) Stock Is Rising Today
at The Street - Wed Sep 24, 11:09AM CDT
Steelcase (SCS) shares are gaining after the company reported second quarter earnings and revenue ahead of analysts expectations.
SCS: 18.01 (+0.15)

Trade-Ideas: Steelcase (SCS) Is Today's Strong On High Relative Volume Stock
at The Street - Wed Sep 24, 9:10AM CDT
Trade-Ideas LLC identified Steelcase (SCS) as a strong on high relative volume candidate
SCS: 18.01 (+0.15)

STEELCASE'S
at Investor's Business Daily - Tue Sep 23, 5:47PM CDT
STEELCASE'S (SCS) Q2 EPS climbed 12.5% to 27 cents, topping by 4 cents. The office furniture maker's sales rose 4% to $786.7 mil, also beating.
SCS: 18.01 (+0.15)

Steelcase posts 2Q profit
AP - Tue Sep 23, 3:37PM CDT
GRAND RAPIDS, Mich. (AP) — Steelcase Inc. (SCS) on Tuesday reported earnings of $30.5 million in its fiscal second quarter.
SCS: 18.01 (+0.15)

Steelcase Reports Second Quarter Results
GlobeNewswire - Tue Sep 23, 3:01PM CDT
Steelcase Inc. (NYSE:SCS) today reported second quarter revenue of $786.7 million and net income of $30.5 million, or diluted earnings per share of $0.24. Excluding restructuring costs, adjusted earnings were $0.27 per share. In the prior year, Steelcase reported $757.6 million of revenue, diluted earnings per share of $0.22 and adjusted earnings of $0.24 per share.
SCS: 18.01 (+0.15)

Indexes Pare Losses As Salix Soars On Buyout Talk
at Investor's Business Daily - Tue Sep 23, 9:56AM CDT
Major averages pared some of their early losses and were mixed in late-morning trading as investors weighed mixed economic reports from China, Europe and the U.S., as well as U.S. airstrikes in Syria. The Nasdaq was up 0.1%, while the S&P 500 was...
BBBY: 69.84 (+1.68), ACT: 250.38 (+2.47), VRX: 128.77 (-3.14), SCS: 18.01 (+0.15), CPRT: 34.01 (+0.45), SLXP: 138.55 (-0.95), ASNA: 12.50 (+0.05)

Steelcase Inc. to Webcast Second Quarter Conference Call
GlobeNewswire - Mon Sep 08, 9:11AM CDT
Steelcase Inc. (NYSE:SCS) will webcast a discussion of its second quarter fiscal year 2015 financial results on Wednesday, September 24, 2014 at 10:00 a.m. ET. Links to the webcast will be available at http://ir.steelcase.com and a replay of the webcast will be available shortly after the call concludes.
SCS: 18.01 (+0.15)

Should You Get Rid of Steelcase (SCS) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 7:43AM CDT
Steelcase is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
CAJ: 30.84 (-0.19), HNI: 46.62 (+0.08), SCS: 18.01 (+0.15)

Herman Miller Remodeling Continues in DWR Deal
at The Street - Fri Jul 18, 11:37AM CDT
Pays $154 million to expand further into home furniture following last year's acquisition of New York's Maharam Fabric.
SCS: 18.01 (+0.15), KNL: 19.77 (+0.15), MLHR: 31.46 (+0.33)

Steelcase Inc. Annual Meeting of Shareholders Announced
GlobeNewswire - Wed Jul 02, 1:13PM CDT
Steelcase Inc. (NYSE:SCS) will hold its Annual Meeting of Shareholders on Wednesday, July 16, 2014, via live webcast only beginning at 11:00 am EDT. The webcast will be accessible at www.virtualshareholdermeeting.com/scs2014. A replay will be available shortly after the webcast concludes.
SCS: 18.01 (+0.15)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SCS, CLC, MBT
at The Street - Tue Jul 01, 9:00AM CDT
SCS CLC MBT are going ex-dividend tomorrow, Wednesday, July 2, 2014, 4:00 AM ET
SCS: 18.01 (+0.15), MBT: 13.77 (-0.61), CLC: 67.40 (+0.60)

5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Jun 29, 12:30PM CDT
There's never a shortage of stocks going the wrong way in any given chunk of time. No stock goes straight up, and sometimes fundamentals can get a bit wobbly. Let's take a closer look at five of this past week's biggest sinkers. Company ...
AMSG: 51.34 (-0.03), SCS: 18.01 (+0.15), RDEN: 17.27 (-0.24), ICPT: 246.98 (+1.04), NQ: 6.98 (+0.11)

This Week's 5 Dumbest Stock Moves
Rick Munarriz, The Motley Fool - Motley Fool - Fri Jun 27, 4:15PM CDT
Stupidity is contagious -- even respectable companies can catch it. As we do every week, let's look at five dumb financial events from this past week that may make your head spin. 1. Open and shut Steelcase Just when you start thinking that...
SCS: 18.01 (+0.15), RDEN: 17.27 (-0.24), WMT: 77.81 (+0.11), VZ: 50.28 (-0.06), GOOG: 542.04 (-3.88)

Steelcase Inc. (SCS) Stock Research Links

SCS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading